Validation of a Smartphone Application for the Assessment of Patients With Mild Cognitive Impairment: MemScreen
NCT ID: NCT03811184
Last Updated: 2019-08-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
400 participants
OBSERVATIONAL
2019-01-17
2020-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The initial evaluation is made most often by a doctor (general practitioner). In case of need for further examination, a neuropsychological report is made in consultation memory by a neuropsychologist, with further cognitive tests.
The Cognitive Neurology Center at Lariboisière Hospital - Fernand Widal has developed a tool on a digital tablet or smartphone to evaluate cognitive functions: MemScreen.
The purpose of this study is to validate this new neuropsychological test on tablet compared to the neuropsychological reference tests.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of the Memory Motivation (MEMO) Web Application Training
NCT04142801
Pilot Testing a New Computer-based Screening Tool to Detect Cognitive Impairment
NCT01220674
Pilot Trial Evaluating Patient Experience With the MemorEM for Patients With Neurological Diseases
NCT07049341
Validation of a Remediation Method for Memory Disorders Using Motor and Emotional Encoding in Patients With Alzheimer's Disease
NCT06105047
Efficacy of MindAhead's Digital Behavioral Activation Therapy in Adults with MCI or Mild Dementia
NCT06149013
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Smartphone / tablet application developed by the Cognitive Neurology Center at Lariboisière - Fernand Widal Hospital to explore a patient with a cognitive disorder.
* The application is a self-test by the patient under the supervision of a doctor.
* The doctor has an account to be able to pass the test to patients.
* The tablet test is anonymous without the possibility to identify the patient.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MemScreen
Each participants will undergo MemScreen : a screening tool on smartphone for detecting mild cognitive impairment.
MemScreen
Neuropsychological test on smartphone or digital tablet, on self assesment.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MemScreen
Neuropsychological test on smartphone or digital tablet, on self assesment.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Performing a neuropsychological assessment less than 6 months old.
* No visual or motor deficiency impeding the use of a digital tablet.
Exclusion Criteria
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
MemScreen
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Julien Dumurgier, MD
Role: PRINCIPAL_INVESTIGATOR
Cognitive Neurology Center of Lariboisiere Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Neurologie Cognitive Hôpital Fernand Widal
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-A02672-53
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.